| 2006P-0151 | Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants | |||||||||||||||||||||||
| FDA Comment Number : | EC3 | |||||||||||||||||||||||
| Submitter : | Dr. Patricia Tetreault | Date & Time: | 06/29/2006 02:06:48 | |||||||||||||||||||||
| Organization : | University of Nebraska | |||||||||||||||||||||||
| Category : | Health Professional | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I encourage you to decide in favor of protecting women and children's health. Given the research that indicates there are toxins found in women's bodies, including breast milk, it is vital to act conservatively to protect health. Please stay the approval letter for silicone-filled breast implants for an indefinite time due to the 2006 peer-reviewed published research finding significant levels of ionized platinum are released after implantation from second and third generation SGFBIs. | ||||||||||||||||||||||||